{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": 1915
        },
        "variant_string_id": "LRRK2 I1915T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes miRNA function, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as deregulated synthesis of E2F1/DP due to impaired miRNA pathway."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses luciferase reporter assays and Western blot analysis to evaluate miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by measuring the impact of LRRK2 on miRNA function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (WT LRRK2) and replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were included, and experiments were performed in triplicate."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to demonstrate the effect of pathogenic LRRK2 on miRNA function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the pathogenicity of the variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant LRRK2 I1915T shows strong evidence of pathogenicity based on its ability to antagonize miRNA function and increase E2F1/DP levels."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": 2019
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes miRNA function, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as deregulated synthesis of E2F1/DP due to impaired miRNA pathway."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses luciferase reporter assays and Western blot analysis to evaluate miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by measuring the impact of LRRK2 on miRNA function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (WT LRRK2) and replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were included, and experiments were performed in triplicate."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to demonstrate the effect of pathogenic LRRK2 on miRNA function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the pathogenicity of the variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant LRRK2 G2019S shows strong evidence of pathogenicity based on its ability to antagonize miRNA function and increase E2F1/DP levels."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": 1441
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes miRNA function, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "No",
          "reasoning": "This variant does not affect miRNA function or cause E2F1/DP overproduction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses luciferase reporter assays and Western blot analysis to evaluate miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by measuring the impact of LRRK2 on miRNA function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (WT LRRK2) and replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were included, and experiments were performed in triplicate."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to demonstrate the lack of effect of this variant on miRNA function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the benign nature of the variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "The variant LRRK2 R1441G shows evidence of being benign as it does not affect miRNA function or cause E2F1/DP overproduction."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": 1915
        },
        "variant_string_id": "LRRK2 I1915T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes miRNA function, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as deregulated synthesis of E2F1/DP due to impaired miRNA pathway."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses luciferase reporter assays and Western blot analysis to evaluate miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by measuring the impact of LRRK2 on miRNA function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (WT LRRK2) and replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were included, and experiments were performed in triplicate."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to demonstrate the effect of pathogenic LRRK2 on miRNA function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the pathogenicity of the variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant LRRK2 I1915T shows strong evidence of pathogenicity based on its ability to antagonize miRNA function and increase E2F1/DP levels."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": 2019
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes miRNA function, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as deregulated synthesis of E2F1/DP due to impaired miRNA pathway."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses luciferase reporter assays and Western blot analysis to evaluate miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by measuring the impact of LRRK2 on miRNA function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (WT LRRK2) and replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were included, and experiments were performed in triplicate."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to demonstrate the effect of pathogenic LRRK2 on miRNA function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the pathogenicity of the variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant LRRK2 G2019S shows strong evidence of pathogenicity based on its ability to antagonize miRNA function and increase E2F1/DP levels."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": 1441
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes miRNA function, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "judgment": "No",
          "reasoning": "This variant does not affect miRNA function or cause E2F1/DP overproduction."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses luciferase reporter assays and Western blot analysis to evaluate miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by measuring the impact of LRRK2 on miRNA function."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (WT LRRK2) and replicates were used in the experiments.",
          "judgment": "Yes",
          "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were included, and experiments were performed in triplicate."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed to demonstrate the lack of effect of this variant on miRNA function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the benign nature of the variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "The variant LRRK2 R1441G shows evidence of being benign as it does not affect miRNA function or cause E2F1/DP overproduction."
    }
  ]
}